152 related articles for article (PubMed ID: 22185025)
21. Hyperuricemia, Type 2 Diabetes Mellitus, and Hypertension: an Emerging Association.
Mortada I
Curr Hypertens Rep; 2017 Sep; 19(9):69. PubMed ID: 28770533
[TBL] [Abstract][Full Text] [Related]
22. [Idiopathic hyperuricemia with overproduction of uric acid].
Mizuta E; Igawa O; Hisatome I
Nihon Rinsho; 2008 Apr; 66(4):675-8. PubMed ID: 18409513
[TBL] [Abstract][Full Text] [Related]
23. [The uric acid cardio-nephropathy].
Viazzi F; Bonino B; Cappadona F; Pontremoli R
G Ital Nefrol; 2017 Mar; 34(Suppl 69):41-48. PubMed ID: 28682028
[TBL] [Abstract][Full Text] [Related]
24. [Hyperuricemia in hypertension].
Tatsuno I; Saito Y
Nihon Rinsho; 2001 May; 59(5):967-72. PubMed ID: 11392000
[TBL] [Abstract][Full Text] [Related]
25. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
Baumgart P
MMW Fortschr Med; 2006 Mar; 148(11):57, 59-60. PubMed ID: 16612965
[No Abstract] [Full Text] [Related]
26. [Endothelial function in patients with arterial hypertension and impaired uric acid metabolism].
Lebedeva MV; Stakhova TIu; Minakova EG; Zaĭtseva LI; Severova MM; Pulin AA
Vestn Ross Akad Med Nauk; 2010; (12):44-6. PubMed ID: 21395065
[TBL] [Abstract][Full Text] [Related]
27. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.
Barbieri L; Verdoia M; Schaffer A; Cassetti E; Marino P; Suryapranata H; De Luca G;
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):181-6. PubMed ID: 25315668
[TBL] [Abstract][Full Text] [Related]
28. [Immunomodulating, metabolic and cardioprotective effects of AT1-angiotensin receptors blocker losartan in patients with coronary heart disease and type 2 diabetes mellitus].
Tepliakov AT; Maianskaia SD; Bolotskaia LA; Vdovina TV; Stepacheva TA; Kuznetsova AV; Lukinov AV; Derbeneva NV; Frants MV; Shilov SN
Ter Arkh; 2009; 81(3):62-9. PubMed ID: 19459427
[TBL] [Abstract][Full Text] [Related]
29. Effect of hyperuricemia on the blood pressure response to antihypertensive agents in hospitalized elderly patients.
Zhu P; Lin F; Lin C; Hong D; Lin K; Chen H
J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):741-6. PubMed ID: 22964647
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome.
Nashar K; Nguyen JP; Jesri A; Morrow JD; Egan BM
Am J Hypertens; 2004 Jun; 17(6):477-82. PubMed ID: 15177518
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y
Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377
[TBL] [Abstract][Full Text] [Related]
32. [The normalized smoothness index and parametric population RDH index of losartan in patients with newly diagnosed hypertension and metabolic syndrome].
Rihácek I; Frána P; Schwarz D; Plachý M; Soucek M
Vnitr Lek; 2010 Sep; 56(9):901-9. PubMed ID: 21137176
[TBL] [Abstract][Full Text] [Related]
33. Hyperuricemia and hypertension.
Feig DI
Adv Chronic Kidney Dis; 2012 Nov; 19(6):377-85. PubMed ID: 23089272
[TBL] [Abstract][Full Text] [Related]
34. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
[TBL] [Abstract][Full Text] [Related]
35. Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients.
Hamada T; Ichida K; Hosoyamada M; Mizuta E; Yanagihara K; Sonoyama K; Sugihara S; Igawa O; Hosoya T; Ohtahara A; Shigamasa C; Yamamoto Y; Ninomiya H; Hisatome I
Am J Hypertens; 2008 Oct; 21(10):1157-62. PubMed ID: 18670416
[TBL] [Abstract][Full Text] [Related]
36. Diabetes: Lowering serum uric acid levels to prevent kidney failure.
Doria A; Krolewski AS
Nat Rev Nephrol; 2011 Aug; 7(9):495-6. PubMed ID: 21808278
[No Abstract] [Full Text] [Related]
37. Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study).
Brodov Y; Behar S; Boyko V; Chouraqui P
Am J Cardiol; 2010 Dec; 106(12):1717-20. PubMed ID: 21126615
[TBL] [Abstract][Full Text] [Related]
38. Serum uric acid levels and renal damage in hyperuricemic hypertensive patients treated with renin-angiotensin system blockers.
Berni A; Boddi M; Fattori EB; Cecioni I; Berardino S; Montuschi F; Chiostri M; Poggesi L
Am J Hypertens; 2010 Jun; 23(6):675-80. PubMed ID: 20203626
[TBL] [Abstract][Full Text] [Related]
39. Relationship between hyperuricemia and chronic kidney disease.
Ohno I
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1039-44. PubMed ID: 22132954
[TBL] [Abstract][Full Text] [Related]
40. The effects of the addition of losartan on uric acid metabolism in patients receiving indapamide.
Nikas S; Rizos E; Milionis H; Bairaktari E; Kalaitzidis R; Siamopoulos K; Elisaf M
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):289-91. PubMed ID: 11881040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
